Department of Internal Medicine, Allergology, Erasmus Medical Center, Rotterdam, The Netherlands.
Department of Internal Medicine, Allergology, Erasmus Medical Center, Rotterdam, The Netherlands.
Ann Allergy Asthma Immunol. 2018 Mar;120(3):300-303. doi: 10.1016/j.anai.2017.08.018. Epub 2017 Oct 7.
Severe allergic reactions, including anaphylaxis, occur during oral food challenges (OFCs) and the first-line treatment of anaphylaxis is epinephrine.
To evaluate the percentage of anaphylactic reactions treated with epinephrine during OFCs and to identify associated factors for the administration of epinephrine.
Children who underwent an OFC with peanut, hazelnut, cow's milk, hen's egg, or cashew nut from 2005 through 2015 in the Netherlands were evaluated. Children with reactions meeting the criteria for anaphylaxis according to the European Academy of Allergy and Clinical Immunology guidelines for food allergy and anaphylaxis were included. Children with an anaphylactic reaction treated with vs without epinephrine were compared. Possible factors associated with the administration of epinephrine, such as age, sex, symptoms consistent with asthma, history of an allergic reaction to the tested allergen, and symptom types during the anaphylactic reaction, were evaluated using logistic regression analysis.
Eighty-three children in clinical and research settings (43% boys; median age, 7 years; range, 1-17) who met the criteria for anaphylaxis were included in this study. Thirty-two of 83 children (39%) with anaphylaxis were treated with epinephrine. Respiratory symptoms during the OFC were treated significantly more often with epinephrine than gastrointestinal symptoms (P = .01).
Only 39% of children with anaphylaxis, according to the guideline criteria, were treated with epinephrine during the OFC and most of these children had respiratory symptoms. There is need for an easy-to-use international guideline for the treatment of allergic symptoms during OFCs.
严重过敏反应,包括过敏反应,在口服食物挑战(OFC)期间发生,过敏反应的一线治疗是肾上腺素。
评估在 OFC 期间用肾上腺素治疗过敏反应的百分比,并确定肾上腺素给药的相关因素。
评估了 2005 年至 2015 年间在荷兰进行花生、榛子、牛奶、鸡蛋或腰果口服食物挑战的儿童。根据欧洲过敏与临床免疫学学会(EAACI)食物过敏和过敏反应指南,纳入符合过敏反应标准的儿童。比较有和无肾上腺素治疗的过敏反应儿童。使用逻辑回归分析评估与肾上腺素给药相关的可能因素,如年龄、性别、符合哮喘的症状、对测试过敏原的过敏反应史和过敏反应期间的症状类型。
在临床和研究环境中,83 名符合过敏反应标准的儿童(43%为男孩;中位数年龄为 7 岁;范围为 1-17 岁)被纳入本研究。83 名过敏反应儿童中有 32 名(39%)接受了肾上腺素治疗。OFC 期间的呼吸道症状比胃肠道症状更常接受肾上腺素治疗(P =.01)。
根据指南标准,只有 39%的过敏反应儿童在 OFC 期间接受了肾上腺素治疗,而且这些儿童大多数有呼吸道症状。需要制定一个易于使用的国际指南,用于治疗 OFC 期间的过敏症状。